BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8978810)

  • 1. [Antitumor effect of TNP-470 against tongue carcinoma model by intratumor administration].
    Ninomiya Y; Matsumoto K; Wakae H; Tomioka T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1993-6. PubMed ID: 8978810
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-tumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue.
    Matsumoto K; Ninomiya Y; Inoue M; Tomioka T
    Int J Oral Maxillofac Surg; 1999 Apr; 28(2):118-24. PubMed ID: 10102393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional changes in lymphatic architecture around VX2 tongue cancer--dynamic changes after administration of antiangiogenic agent.
    Seki S; Fujimura A
    Lymphology; 2003 Dec; 36(4):199-208. PubMed ID: 14992572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution.
    Kamei S; Okada H; Inoue Y; Yoshioka T; Ogawa Y; Toguchi H
    J Pharmacol Exp Ther; 1993 Jan; 264(1):469-74. PubMed ID: 7678651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lymphatic metastasis in a syngeneic rat fibrosarcoma model by an angiogenesis inhibitor, AGM-1470.
    Futami H; Iseki H; Egawa S; Koyama K; Yamaguchi K
    Invasion Metastasis; 1996; 16(2):73-82. PubMed ID: 9030242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of liver metastases in rabbits by arterial infusion of angiogenesis inhibitor, TNP-470].
    Koishi Y; Taniguchi H; Tanaka H; Higashida T; Takeuchi K; Miyata K; Koyama H; Masuyama M; Takahashi T
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2118-20. PubMed ID: 7944417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic liver tumors by intermittent repetitive injection of an angiogenesis inhibitor using an implantable port system in a rabbit model.
    Kuwata Y; Hirota S; Sako M
    Kobe J Med Sci; 1997 Apr; 43(2):83-98. PubMed ID: 9385787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of carcinomatous peritonitis by the angiogenesis inhibitor TNP-470 in mice: analysis of timing and doses for intraperitoneal administration].
    Tsujimoto H; Osaki K; Ohyama T; Sakakibara T; Ohgaki M; Imanishi T; Yamasaki J; Shirasu M; Shimotsuma M; Hagiwara A
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1527-30. PubMed ID: 7574750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticancer chemotherapy apropos of bleomycin].
    Miyake H; Suzuki Y; Kunishige N
    Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):677-89. PubMed ID: 4123695
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-tumor effects of an angiogenesis inhibitor, TNP-470 (AGM-1470) alone and in combination with cisplatinum, and changes in serum copper levels in liver cancer bearing rats].
    Matsuoka S
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):69-80. PubMed ID: 8727376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
    Kato T; Sato K; Kakinuma H; Matsuda Y
    Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
    Kudelka AP; Levy T; Verschraegen CF; Edwards CL; Piamsomboon S; Termrungruanglert W; Freedman RS; Kaplan AL; Kieback DG; Meyers CA; Jaeckle KA; Loyer E; Steger M; Mante R; Mavligit G; Killian A; Tang RA; Gutterman JU; Kavanagh JJ
    Clin Cancer Res; 1997 Sep; 3(9):1501-5. PubMed ID: 9815836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a medium-chain triglyceride solution of the angiogenesis inhibitor TNP-470 (AGM-1470) when administered via the hepatic artery to rats bearing Walker 256 carcinosarcoma in the liver.
    Yanai S; Okada H; Misaki M; Saito K; Kuge Y; Ogawa Y; Toguchi H
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1267-73. PubMed ID: 7527853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis.
    Ahmed MH; Konno H; Nahar L; Tanaka T; Naito Y; Nakamura S; Baba S
    J Surg Res; 1996 Jul; 64(1):35-41. PubMed ID: 8806471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.
    Bhargava P; Marshall JL; Rizvi N; Dahut W; Yoe J; Figuera M; Phipps K; Ong VS; Kato A; Hawkins MJ
    Clin Cancer Res; 1999 Aug; 5(8):1989-95. PubMed ID: 10473076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
    Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin.
    Chakravarti A; Bhargava R
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1367-9. PubMed ID: 23732020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic efficiency of an angiogenesis inhibitor, TNP-470, against carcinomatous peritonitis in rodents].
    Ozaki K; Takahashi T; Hagiwara A; Shimotsuma M; Sakakura C; Sasaki S; Shirasu M; Tsujimoto H; Oyama T; Sakakibara T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1575-7. PubMed ID: 8373222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early experiments with arterial infusion of adriamycin in regional antineoplastic therapy].
    Di Pietro S; Cunsolo A; De Palo GM
    G Clin Med; 1969 Dec; 50(12):1144-9. PubMed ID: 5386464
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of neoadjuvant chemotherapy on metastasis of oral squamous cell carcinoma in a mouse model.
    Kawashiri S; Noguchi N; Tanaka A; Nakaya H; Kato K; Yamamoto E
    Oral Oncol; 2009 Sep; 45(9):794-7. PubMed ID: 19200774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.